Is suPAR the strongest marker for COVID-19 risk identification?

June 26th, 2020|

By: Jesper Eugen-Olsen, PhD, Copenhagen University Hospital Hvidovre, Denmark The corona virus SARS-CoV-2 pandemic puts tremendous pressure on hospital resources and capacity. Clinical markers of progression are urgently needed in order to quickly discharge patients, who will not [...]